Clinical Outcomes, Nutritional Status, Exercise and Psychosocial Factors in Pediatric Hematopoietic Cell Transplant (CONSEPT)

January 24, 2024 updated by: University of Michigan Rogel Cancer Center
Children who receive hematopoietic cell transplants (HCT) are at high nutritional risk due to comorbidities and complications that are likely to develop before, during and after transplant. Prior to transplant, many children undergo multiple rounds of chemotherapy which affect appetite and cause gastrointestinal toxicities that limit food intake. During transplant, painful mucositis makes it difficult to consume adequate nutrients and often children will require nutrition support such as parenteral or enteral nutrition. Energy imbalance and physical deconditioning following transplant can result in loss of lean body mass and functional impairment; these nutritional side effects are exacerbated if the child develops graft-versus-host disease. After transplant, a substantial number of childhood cancer survivors become overweight and develop metabolic syndrome. However, little is known about the prevalence and distribution of pediatric malnutrition (under-nutrition as well as obesity), the psychosocial factors that affect dietary intake and how the quality of the child's food intake and physical activity level throughout the transplant process might affect body composition and clinical outcomes. In this exploratory study, we will monitor nutritional status in pediatric patients undergoing HCT. This study will test the feasibility of collecting patient-reported dietary intake data along with anthropometric, body composition, functional status and psychosocial measurements that may influence dietary intake in pediatric patients undergoing HCT. The data collected in this preliminary analysis will inform future interventional studies.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

55

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Ann Arbor, Michigan, United States, 48109
        • University of Michigan Health System

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 months to 23 years (Child, Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Pediatric hematopoietic cell transplant patients

Description

Inclusion Criteria:

  • Pediatric hematopoietic cell transplant patients, aged 2-25 years.
  • Participants and/or at least one caregiver must speak, read and understand English.

Exclusion Criteria:

  • Children younger than 2 years old at the time of their transplant or any child who is still breastfeeding will not be eligible due to the nature of the questionnaires and measurements.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Pediatric patients
This is an observational study. Validated measures of nutritional status, dietary intake, body composition, functional status and psychosocial factors will be used to measure outcomes in study patients at 4 time-points: (1) pre-HCT (Baseline), (2) 30-days post-HCT, (3) 100-days post-HCT and (4) one year post-HCT.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility of comprehensive nutrition assessments in pediatric HCT patients
Time Frame: 1 year post-HCT
Feasibility is defined as completion of comprehensive nutrition assessment by at least 50% of participants.
1 year post-HCT

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dietary intake
Time Frame: baseline (pre-HCT); day 30, day 100 and 1 year post-HCT
baseline (pre-HCT); day 30, day 100 and 1 year post-HCT
Determination of lean body mass measured using air displacement plethysmography (BOD POD)
Time Frame: baseline (pre-HCT); day 100 and 1 year post-HCT
baseline (pre-HCT); day 100 and 1 year post-HCT
Hand grip strength
Time Frame: baseline (pre-HCT); day 30, day 100 and 1 year post-HCT
baseline (pre-HCT); day 30, day 100 and 1 year post-HCT
PedsQL Pediatric Quality of Life Inventory
Time Frame: baseline (pre-HCT); day 30, day 100 and 1 year post-HCT
Participants 10 years or older
baseline (pre-HCT); day 30, day 100 and 1 year post-HCT
PedsQL Cognitive Functioning Scale
Time Frame: baseline (pre-HCT); day 30, day 100 and 1 year post-HCT
Participants 10 years or older
baseline (pre-HCT); day 30, day 100 and 1 year post-HCT
Dietary Patient Self-Efficacy Survey
Time Frame: baseline (pre-HCT); day 30, day 100 and 1 year post-HCT
Participants 10 years or older
baseline (pre-HCT); day 30, day 100 and 1 year post-HCT

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 9, 2016

Primary Completion (Actual)

February 10, 2020

Study Completion (Actual)

February 10, 2020

Study Registration Dates

First Submitted

March 17, 2016

First Submitted That Met QC Criteria

April 5, 2016

First Posted (Estimated)

April 12, 2016

Study Record Updates

Last Update Posted (Estimated)

January 25, 2024

Last Update Submitted That Met QC Criteria

January 24, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • UMCC 2015.108
  • HUM00102331 (Other Identifier: The University of Michigan)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

3
Subscribe